Stakeholder Preferences Studies
Evaluate the preferences of patients, healthcare personnel, caregivers, and payers to demonstrate product value.
Patient, caregiver, provider and payer preferences. Identified and quantified.
Stakeholder preferences have broad implications. Alignment helps meet regulatory requirements, realize the broadest market access, or achieve optimal post-launch value for your product. The US Food and Drug Administration (FDA) and European Medicines Agency (EMA) are increasing their focus on patient preference in regulatory submission packages. CernerEnviza℠ will recommend the optimal stated preference methodology, e.g. discrete choice experiment (DCE), best-worst scaling (BWS), etc., to meet your research objectives throughout the product lifecycle. We will also apply our global recruiting capabilities to ensure recruitment with the right degree of precision.